Open access peer-reviewed chapter

Ion Channels in Aging and Aging-Related Diseases

Written By

Vidhya Rao, Simon Kaja and Saverio Gentile

Submitted: 06 November 2015 Reviewed: 26 April 2016 Published: 31 August 2016

DOI: 10.5772/63951

From the Edited Volume

Molecular Mechanisms of the Aging Process and Rejuvenation

Edited by Naofumi Shiomi

Chapter metrics overview

2,311 Chapter Downloads

View Full Metrics


Aging in humans is the decline over function of time of biological processes that include the capacity to grow, to reproduce, to interact, and to adapt, resulting in progressive organ malfunctions, illnesses, and ultimately death. As the average life expectancy is estimated to be above 60 years for about 25% of the world's population by 2050, understanding the causes of and designing treatments for aging-related disease is a compelling priority. Although every organ and tissue undergoes the process of aging, it appears that only few pathogeneses are typically detected with high frequency in elderly individuals. These include cardiovascular disease, neurodegeneration, vision loss, and cancer. Therefore, aging could be measured by monitoring the occurrence and progression of these diseases. However, each of these medical conditions alone is not a good marker for aging as elder patients present comorbid chronic conditions. In addition, treatment of one disease does not significantly prolong life expectancy. Therefore, it appears that a possible antiaging therapeutic strategy should consider simultaneous treatment of several diseases or move toward identification of a common target among the biological processes involved in aging. In this chapter, we will discuss some of the basic concepts of the role of ion channels in aging and will present an overview of the function of ion channels in some of the most common aging-related diseases.


  • ion channels
  • aging
  • aging-related diseases
  • sinoatrial node
  • neurodegeneration
  • glaucoma
  • cancer

1. Introduction

Ion channels are pore membrane-associated proteins that allow movement of ionic fluxes between intracellular and extracellular fluids and within intracellular compartments. About 1.5% of the human genome encodes more than 400 ion channels. In addition, heteromerization and alternative splicing further increase functional diversity of ion channels [13].

Most ion channels are selective as they can discriminate between electrical charge and size of ions and they can allow unidirectional movement of only a specific ion (mostly K+, Na+, Ca2+, or Cl) through the pore. Changes of ionic fluxes and, consequently, variations of electrical charge across membranes control virtually every cellular event including contraction, neuronal conductance, secretion, proliferation, and cell death. Therefore, abnormal changes of ionic gradients can underlie age-dependent decline of physiological functions. In addition, malfunction of ion channels is often associated with organ failure [4] during the process of aging.

In a resting state, ATP-driven pumps generate and maintain ionic gradients resulting in high intracellular K+ (the most abundant intracellular ion) and low Na+ and Ca2+. In addition, the cytosolic surface membrane of all living cells is characterized by the accumulation of a net negative electrical charge than the extracellular surface of the membrane (membrane potential) that can range from −20 mV in epithelial nonexcitable cells to −100 mV in neurons. Because of this separation of electric charge and ionic concentrations across the membrane, opening of a Na+ ion channel produces a flow of a positive charge (current, i) caused by the movement of Na+ ions from the extracellular environment to the cytosol (Na+ current, iNa+). The augmented concentration of positive charges in the cytosol decreases the net negative charge with a process called depolarization. In plants, depolarization is achieved by an outward Cl- flux.

In neurons and muscle cells, such as cardiac myocytes, depolarization is a critical event that underlies neuronal signaling and contraction. Depolarization activates more Na+ (via a positive feedback), K+, and Ca2+ channels and the respective ions will cross the membrane according to their electrochemical gradients. Therefore, K+ leaving the cells will counteract depolarization, an event called repolarization. Inactivation of Na+ and Ca2+ channels in combination with the outward fluxes of K+ will produce the falling phase of the action potential which will continue until the ionic balances across the membranes are reestablished (resting phase). Each cell type presents a collection of ion channels that shape amplitude and duration of the action potential differently. For example, in neurons, changes of ionic fluxes occur very rapidly producing action potentials with fast depolarization and repolarization (lasting less than 1 ms) that propagates as unidirectional waves along the axon. Frequencies, duration, and amplitudes of action potentials produce neuronal signaling that guarantees transfer and elaboration of information from different body compartments, external to internal environment, and vice versa [5].

In the heart, action potentials are much slower (400 ms) than in neurons and they mostly serve the purpose to control contraction. This event is regulated by a collaborative effort between surface membrane and intracellular Ca2+ channels (ICCs) (e.g., ryanodine receptors, RyRs) in which the initial small amount of Ca2+ ions entering the cell from the extracellular environment bind and activate RyRs channels located on intracellular Ca2+ stores. This event, called Ca2+-induced Ca2+ release, produces large changes of cytosolic Ca2+ concentration that is used by contracting fibers to produce motion and guarantee a conversion of an electrical stimulus into a mechanical response [6].


2. Ion channels in the aging mosaic of the sinoatrial node (SAN)

The sinoatrial node is a specialized bundle of neurons that innervate the heart and act as a “pacemaker” by generating electrical impulses at regular intervals that allow the heart to contract rhythmically. Typically, SAN dysfunction (SND) can be related to the use of specific medications (e.g., beta blockers) [7]; however, SAN function is known to decline during aging [8], resulting in pacemaker diseases in senior people. Unfortunately, SND can be corrected only by treating the extrinsic causes. Clinical manifestation of aging-dependent SND can be associated with a dramatic alteration of a series of parameters that can range from an increased action potential duration of the neurons composing the SAN to a reduction of the intrinsic heart rate [8] (IHR; defined as the rate at which the heart contracts without the contribution of the SAN and hormones). These phenomena are directly associated with changes in the activity of several ion channels that fail to control outward and inward ionic fluxes properly in the SAN and cardiac muscle. Interestingly, several study focusing on understanding age-dependent changes of gene expression revealed that expression of several channels are altered in the SAN and cardiac myocytes of aged animals. Perhaps counterintuitively, it was observed that in aged animals Na+, Ca2+, and K+ channels increased their expression level in the SAN and atrial muscle [912].

It is predictable that an increased expression of Na+ and Ca2+ channels would produce larger Na+ and Ca2+ fluxes. The consequent increased cytosolic concentration of these two ions in neurons could explain the elongation of the aging-dependent action potential duration in the SAN because, for example, more time is required to remove Ca2+. In contrast, increased K+ currents would repolarize the cells faster and therefore increased K+ efflux should accelerate the action potential duration.

Age-dependent changes of ion channel expression can also be specific to cardiac myocytes. For example, a significantly decreased RyR expression level has been found only in atrial cells that may be responsible for the age-dependent reduction of the IHR [9]. Furthermore, recent studies showed that an abnormal cytosolic Ca2+ concentration due to upregulation of the transient receptor potential vanilloid type 2 (TRPV2) calcium channel could cause alteration of posttranslational modification of progerin, which can contribute to the phenotype of premature aging linked to Hutchinson-Gilford progeria syndrome (HGPS) [13, 14].


3. Ion channels in the aging of the nervous system

The human nervous system is composed of two parts, the central nervous system (CNS) and the peripheral nervous system (PNS). Cells of the human nervous system mostly comprise neuronal cells, whose axons bundle in the PNS and nonneuronal cells such as glia cells, microglia, astrocytes, and oligodendrocytes. As any other cell, all cells of the nervous system are susceptible to aging and although aging dramatically increases the risk of developing cognitive disorders that are typical of the CNS such as Alzheimer’s disease (AD) or PNS such as amyotrophic lateral sclerosis, only few elders contract these pathologies (;; This suggests that a purely genetic origin of these diseases linked to aging is unlikely as individuals can live for over 100 years without any overt behavioral sign of neurodegeneration. In addition, these diseases affect particular populations of cells in specific areas of the brain suggesting that perhaps aging is not the trigger of these diseases but only worsens preexisting conditions.

Changes in Ca2+ homeostasis have been linked to aging-dependent deterioration of neuronal activity [1520]. However, it is not yet clear whether it is a decreased or increased cytosolic Ca2+ concentration that mediates its noxious effects on brain performance during aging. For example, Ca2+ channels have been found to be reduced in genetically modified mice with accelerated age-dependent decay in learning and memory [21, 22]. However, this conclusion is contradicted by another study in which it is demonstrated that a long-lasting intracellular Ca2+ might render neurons vulnerable to age [22]. Furthermore, elegant work by the Stutzmann laboratory reported an increase in type 2 RyR transcripts in brains with mild cognitive impairment compared to those with no cognitive impairment. In addition, they found a reduction in a specific type 2 RyR splice variant that is associated with antiapoptotic function in brains of patients with mild cognitive impairment and Alzheimer’s disease [23].

3.1. Reactive oxygen species (ROS) and ion channels in aging

Although there is a considerably large amount of studies on aging-related neurodegenerative diseases, very little is known about the process of aging in normal neurons. Nevertheless, it is generally accepted that neurons of an aging brain are characterized by accumulation of reactive oxygen species over time that are probably generated by an altered target of rapamycin (TOR) pathway [24]. However, ROS has also a protective role in neurons but the mechanism that control the threshold to which ROS become toxic is still heavily debated.

The deleterious effects of free radicals on neuronal homeostasis can be attributed to the ability of these chemical species to interact with a large variety of targets such as DNA and lipids. However, recent research has brought to light that activity of several neuronal ion channels can significantly change upon chemical interaction with free radicals and that this event can be related to aberrant cognitive functions during aging. For example, oxidizing agents dramatically inhibit Na+ channels activity without affecting the concentration of the channels at the surface membrane suggesting a direct effect of the agent on the Na+ channel [25]. Inhibition of Na+ channel activity dampens the ability to produce enough depolarization to generate an action potential and therefore affects the overall brain function.

Oxidation of K+ channels that are expressed in brain neurons has been reported. For example, the activity of K+ channels expressed in the hippocampus (which is the part of the brain that controls memory formation) can be increased by ROS [26] resulting in an inhibition of neuronal excitability and possibly incapacity to form or retain memory during aging. Interestingly, several studies have shown that ROS can increase or decrease cytosolic Ca2+ according to the type of Ca2+ channel analyzed. For example, oxidation of the “L-type” Ca2+ channel decreased Ca2+ currents [27]. However, the oxidative activity of β-amyloid protein (Aβ) produced in the brains of Alzheimer’s patients increased the activity of L-type Ca2+ [28, 29], suggesting that distinct oxidative agents can exert different effects on Ca2+ homeostasis. In contrast, reducing agents have been reported to increase activity of the “T-type” calcium channel [30]. This suggests that ROS agents can increase cytosolic Ca2+ concentration and that this event can contribute to loss of neuronal function in aging. Inositol 1, 4, 5-trisphosphate (IP3) receptors (IP3Rs) and RyRs are the two major intracellular Ca2+ channels that release Ca2+ from neuronal intracellular stores such as the endoplasmic reticulum (ER).

Intracellular Ca2+ channels mediate numerous Ca2+-dependent processes, including cellular growth and development, gene expression, and neurotransmission [3140]. Therefore, it is not surprising that aberrant ICC function has been implicated in aging and several age-related pathologies including Alzheimer’s disease, Huntington’s disease (HD), and glaucoma [4148]. Phosphatidylinositol and IP3 levels are reduced in brains of patients with AD and the ensuing smaller number of IP3 binding sites correlates with the number of amyloid plaques and neurofibrillary tangles [1924]. Importantly, similar IP3R dysfunction was found in in vitro models for AD including primary neuronal cultures from mouse models of AD [44, 49, 50] and cortical neurons exposed to β-amyloid protein [49]. These findings are particularly interesting, given the selective response of IP3R to elevated levels of oxidative stress. IP3R-mediated Ca2+ release was increased following activation of M3 muscarinic receptors under conditions of elevated oxidative stress [51]. Similarly, nonlethal oxidative stress in neuronal cells resulted in a selective upregulation at both the transcriptional and translational levels of type 2 IP3Rs [52]. These channels exhibit the strongest affinity for the endogenous ligand, IP3, and are preferentially expressed in the membranes of the nuclear envelope, where they mediate nuclear Ca2+ release [5255]. This nuclear Ca2+ release is thought to control gene expression responsible for cellular survival and death pathways, and therefore, represents a promising drug target for neurodegenerative diseases [56]. This is exemplified by the recent finding that homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 (HERPUD1) is cytoprotective by preventing IP3R-mediated Ca2+ transfer from the ER to mitochondria [57]. Analogously to IP3Rs, several neurodegenerative and age-related disorders show RyR dysfunction contributing to disease pathology and progression. AD patients exhibit changes in neuronal RyR expression and in ryanodine binding that correlates with cognitive decline and Aβ deposition [42].

3.2. Aging of the nonneuronal cells in the nervous system

The vast amount of cells in the brain is nonneuronal cells such as glia, microglia, astrocytes, and oligodendrocytes. These cells maintain homeostasis, form myelin, and, importantly, they can provide protection to the CNS and PNS as they act as the first and main form of neuronal immune defense. Microglia acts as the resident innate immune system in the brain as they respond to and propagate inflammatory signals (e.g., impending from PNS) by producing proinflammatory cytokines that ultimately can generate cognitive consequences. Several clinical and experimental studies reported that both increased oxidative stress and increased inflammation are (among others) hallmarks of brain aging [30, 58]. Remarkably, it has been found that activation of microglia is dependent on the expression of the Kv1.5 potassium channel and β-amyloid peptide induces expression of the Kv1.5 potassium channels in microglia [5961]. This suggests that increased oxidative stress in aging could produce inflammation by upregulating K+ channels in microglia and that alteration of ion channels could be one of the possible causes of aging-dependent decline of neuronal functions.


4. Ion channels and glaucoma

Glaucoma is an age-related, progressive optic neuropathy that manifests with pathological changes in the optic nerve, activation and remodeling of optic nerve head astrocytes (ONHAs), and slow progressive death of retinal ganglion cells, often leading to blindness. Although the exact pathophysiology is still not completely understood, there is evidence to support ischemic, mechanical, and inflammatory components. In an effort to protect the integrity of the optic nerve and prevent the loss of retinal ganglion cells, research efforts have recently concentrated on glioprotection approaches targeting ONHAs [62, 63]. Glia and neuronal cells alike utilize fine-tuned calcium signaling pathways to control physiological functions. Recent studies have revealed complex intracellular Ca2+ signaling pathways in primary ONHA culture [55] and for the first time described a differential distribution of type 2 IP3Rs and type 2 RyRs in the ER and the membranes of the nuclear envelope. Hence, it is likely that these receptor subtypes activate specific Ca2+-sensitive genes that determine cellular fate. Of particular interest for the role of aberrant Ca2+ signaling in glaucoma is the finding that exposure of ONHAs to elevated hydrostatic pressure, as a model for increased intraocular pressure in glaucoma, results in the differential upregulation of type 2 RyRs [64]. Given the nuclear membrane localization of type 2 RyRs in ONHAs [55], it is likely that RyR-mediated Ca2+ release differentially activates gene expression. Similar pathways of calcium signaling have been identified in astrocytes from other parts of the CNS and recently been reviewed in detail [65].


5. Ion channels and cancer

Cancer is a group of diseases that claim about 8.4 million lives every year ( Although in the past decades, medical research has dramatically improved prevention, diagnosis, and treatment of cancer and despite being among the most preventable diseases, cancer remains a leading cause of death worldwide.

Virtually, cancer can develop in any tissue and although each cancer type can be characterized by its unique features, the basic mechanisms that generate cancers are similar in all forms of the diseases. In a normal and healthy tissue, cell proliferation and cell death are controlled by a very complex, timely, and integrated signaling network that includes a series of checkpoints to ensure proper division factors of the cell or death. Cancer originates from an uncontrolled proliferation of cells that evade cell death and can eventually invade and/or outspread into other body compartments (metastasis).

Cancer can be caused by a multitude of environmental factors that can be external such as smoking, sun exposure, and/or internal such as inherited faulty genes and/or infections. Although there can be a significant difference in the prevalence of cancers among different societies, overall cancer can affect every human being. Accordingly, aging is the highest single risk factor for developing cancer [66]. Recently, several ion channels have been found to play a major role in maintaining homeostasis of nonexcitable cells (Figure 1).

Figure 1.

Schematic representation of the contribution of different ion channels to the membrane potential in function of time (e.g., nonexcitable cell vs. neuronal action potential). Overexpression and/or upregulation (e.g., via hormone-dependent regulation) of certain ion channels can contribute to suppress differentiation and increase duplication rate resulting in the generation of a cancerogenic phenotype.

In addition to the traditional role of allowing movements of ions across membranes, ion channels can also control mechanisms of transport, secretion, cell volume, and protein synthesis. For example, glucose transport is controlled by gradients of Na+ [67, 68]. Furthermore, several transcription factors or proteins involved in secretory mechanism are activated by Ca2+ [69, 70]. Therefore, changes of intracellular ionic concentrations can regulate a variety of cellular event ranging from production of energy to protein synthesis, which are necessary for the ultimate process of cellular duplication. Several studies have reported that cancer cells of different histogenesis can express specific ion channels that can play an important role during proliferation [71].

One of the better characterized ion channels in cancer is the Kv11.1 (hERG1) potassium channel. This potassium channel is encoded by the human ether-a-go-go related gene 1 (hERG1), which has been found typically expressed in the mammalian heart in which it play a fundamental role in controlling repolarization and duration of action potential [72]. Remarkably, hERG1 channel has also been found expressed in different nonexcitable cancer cells but not in the organ from which the tumor has originated [73]. This suggests that the presence of this channel might provide a selective advantage to proliferation. Blockade or stimulation of hERG1 channel activity determined a strong inhibitory effect on cancer cell proliferation [7478]. In addition, complete removal of the hERG1 protein from breast cancer cells determined death by activation of apoptosis [78]. These events indicate that the hERG1 is very important for cancer biology and its activity is kept under strict control.

Interestingly, the inhibitory effect on cell proliferation as a consequence of chronic stimulation of hERG1 channel was characterized by activation of a “cellular senescent program” [76, 79]. Senescent cells were initially described by Hayflick and Moorhead [80] as cells that have lost the ability to duplicate, though they may not die. Today, cellular senescence is defined as a permanent arrest of the cell cycle induced by a progressive increase of stresses [8183]. At this time, it is not known what kind of stresses hERG1 agonists produce on cancer cells but their effect is mediated by permanent arrest of the cell cycle, increased expression of tumor suppressors (e.g., p21waf/cif and p16INK4A) and decreased level of tumor markers (e.g., cyclins) resulting in a potent inhibition of cell proliferation [8486]. This suggests that, by taking advantage of the ability to accelerate aging in cancer cells, hERG1 agonists could be used as an anticancer therapeutic strategy.

Other ion channels have been found playing fundamental roles in regulating biochemical signaling that underline important events in cancer biology which includes metastasis. Overtime, cancer cells acquire the ability to move and invade surrounding tissues by protruding membrane structures (invadopodia and pseudopodia) [87] through the intracellular space of the host organ. Remarkably, it has been discovered that ion channels are fundamental factors for regulation of invasion and migration of cancer cells. For example, the concerted activity of Ca2+, K+, and Cl channels that can exquisitely colocalize on the glioma surface membrane generates fluxes of ions and water that creates shrinkage of the membrane with consequent formation of invadopodia [88]. A direct consequence of this event is that cancer cells can move across tissue barriers (e.g., blood vessel) and colonize other body compartments. In addition, it has been shown that overexpression of Kv10 channels in which ion flux has been obstructed by a specific mutation did not lose the ability to promote cell proliferation [89, 90]. Although the mechanism through which this event occurs is not clearly understood, it appears that these channels can regulate activities of proteins that control proliferative cell signaling also when ion fluxes are not involved.

As hormones control most of the major organ functions by activating a variety of cellular signaling, it is not surprising that ion channels can be downstream effectors of hormone receptors. Growth of many cancers can depend on altered expression of hormone receptors. For example, high percentage of breast cancers are very sensitive to the action of insulin and/or sex hormones such as estrogen [91] or prostate cancer to testosterone [92]. Hormones can control ion channel activity by increasing their synthesis or by activating membrane signaling pathways (Figure 1). For example, hormones that bind G protein-coupled receptors (GPCR) produce release of the active βγsubunit of the heteromeric GTPase complex that ultimately binds and activates K+ channels (e.g., GIRK). Alternatively, soluble hormone receptors can activate nongenomic signaling resulting in stimulation of kinases or phosphatases that modulate activity of ion channels by directly targeting these proteins [9395]. Furthermore, as secretion is vastly controlled by intracellular changes in Ca2+ concentrations (e.g., Ca2+-dependent insulin secretion), hormones must rely on ion channel function to be released in the body environment [96]. It is well established that with aging, organs become less sensitive to hormones. Although several examples of hormone-regulated ion channel activities have been proposed, knowledge on the role of these signalings in pathological conditions such as cancer, age-related disease, and/or aging is very limited. Therefore, it appears that there is a compelling need to study the role of hormonal regulation of ion channels to better understand both aging and cancer.


6. Modulation of ion channels

Another level of complexity of regulation of ion channels is added by a number of modulatory proteins that have been shown to bind channels and alter their biophysical properties.

Figure 2.

Presenilins differentially regulate RyR-mediated Ca2+ release.

Representations of an individual RyR and its interaction with presenilin are shown in the top panels. Corresponding graphs below illustrate characteristics of Ca2+ transients mediated by RyR activity. Whole-cell cytosolic calcium concentrations (ordinate) are plotted over time (abscissa) to show the changes in the kinetics of Ca2+ transients dependent on presenilin binding to the RyR. Seesaws depict a predominant effect of presenilin 1 (PS1) over presenilin 2 PS2 or PS2 over PS1, as seen in young and aged animals, respectively [48]. (A) Binding of the PS1 N-terminal fragment to RyR increases open probability and results in heightened calcium release and fast channel inhibition by calcium at the RyR’s inhibitory low affinity Ca2+ binding site. (B) Binding of PS2 to the RyR blocks inhibition at the low affinity Ca2+ binding site resulting in an increased duration of the Ca2+ transient.

This figure was modified from reference [103], which was published under Open Access licence (®2015 by Andrew J. Payne et al.).

One of the best examples of involvement of ion channel modulation in aging includes Homer/Vesl proteins and the group of presenilins. The group of Homer proteins (reviewed in [97]) is a family of ubiquitously expressed scaffolding molecules. Through a conserved binding motif, Homer proteins interact with a number of synaptic proteins. Homer 1 proteins directly interact with IP3Rs, RyRs, the group of transient receptor potential canonical (TRPC) channels, as well as mGluRs and some voltage-gated Ca2+ channels (reviewed in [97]). Intriguingly, in addition to enhancing synaptic transmission and providing a means of regulating excitability through tethering plasma membrane proteins to receptors and channels in the ER by formation of Homer tetramers, Homer proteins can alter the biophysical properties of their binding partners [98100]. These interactions, especially with intracellular Ca2+ channels, have recently attracted increased interest due to their alterations in age-related diseases in the nervous system. For instance, in the aging brain, loss of the short isoform, Homer 1a, correlated with the loss of cognitive and motor function in mice [46]. Similarly, upregulation of the long isoform, Homer 1c, in the retina of glaucomatous mice showed a statistically significant association with severity of the disease phenotype and disease progression [47]. Furthermore, loss of Homer 1c immunoreactivity at glutamatergic synapses after experimental stroke was identified as a potential biomarker for early neurodegenerative processes, prior to initiation of apoptotic pathways [101]. Similarly, binding of presenilin proteins to RyRs results in a functional change of intracellular Ca2+ release [102105]. Recent studies have demonstrated that altered levels of presenilin proteins in the aging brain correlate with the presence and severity of impairments in cognitive and motor function [48]; Figure 2), identifying the group of presenilins as putative drug target for neurodegeneration. In summary, intracellular Ca2+ channels are critical mediators of intracellular Ca2+ homeostasis and respond differentially to aging and pathological stimuli including oxidative stress. Furthermore, intracellular Ca2+ signaling is differentially regulated in various cell types and tissues and by a large number of modulators, providing a multitude of targets for pharmaceutical intervention in conditions characterized by neurodegeneration and aging.


7. Perspective

Aging is a process common to all living organisms that is associated with a progressive failure to adapt to changes in the environment. As ion channels are evolutionary conserved proteins that all cells of all living creatures utilize to sense and adapt to variations of both extracellular and intracellular environments, it is not surprising that malfunction of ion channels increases disease susceptibility that often simulates ailments of getting older. This suggests that drugs targeting ion channels can hold promise for treating aging. However, in consideration of the fact that more than 400 genes encoding for ion channels subunits have been identified so far, the role of ion channels in aging and aging-related diseases remains significantly underexplored. In addition, aging-dependent alteration of a particular ion channel appears to be organ and/or tissue-specific indicating that pharmacologic therapies targeting a specific ion channel should be tailored to a particular organ.

The ultimate consequence of all diseases is pain which appears to get worse with age and can have serious negative impact on quality of life. In recent time, a substantial increased awareness on the critical role of ion channels in diseases and pain has been achieved so that ion channels are emerging as novel therapeutic targets in the treatment of pain.



This material is the result of work supported with resources and the use of facilities at the Edward Hines Jr. VA Hospital, Hines, IL. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. Additional support by the Dr. John P. and Therese E. Mulcahy Endowed Professorship in Ophthalmology (SK) and by the Cronk Family Foundation is gratefully acknowledged.


  1. 1. Lee A, Fakler B, Kaczmarek LK, Isom LL. (2014) More than a pore: ion channel signaling complexes. J Neurosci, 34, 15159–15169.
  2. 2. Brueggemann LI, Gentile S, Byron KL. (2013) Social networking among voltage-activated potassium channels. Prog Mol Biol Transl Sci, 117, 269–302.
  3. 3. Hille B. (1978) Ionic channels in excitable membranes. Current problems and biophysical approaches. Biophys J, 22, 283–294.
  4. 4. Kass RS. (2005) The channelopathies: novel insights into molecular and genetic mechanisms of human disease. J Clin Invest, 115, 1986–1989.
  5. 5. Bean BP. (2007) The action potential in mammalian central neurons. Nat Rev Neurosci, 8, 451–465.
  6. 6. Amin AS, Tan HL, Wilde AA. (2010) Cardiac ion channels in health and disease. Heart Rhythm, 7, 117–126.
  7. 7. Jensen PN, Gronroos NN, Chen LY, Folsom AR, deFilippi C, Heckbert SR, Alonso A. (2014) Incidence of and risk factors for sick sinus syndrome in the general population. J Am Coll Cardiol, 64, 531–538.
  8. 8. Haqqani HM, Kalman JM. (2007) Aging and sinoatrial node dysfunction: musings on the not-so-funny side. Circulation, 115, 1178–1179.
  9. 9. Tellez JO, McZewski M, Yanni J, Sutyagin P, Mackiewicz U, Atkinson A, Inada S, Beresewicz A, Billeter R, Dobrzynski H, Boyett MR. (2011) Ageing-dependent remodelling of ion channel and Ca2+ clock genes underlying sino-atrial node pacemaking. Exp Physiol, 96, 1163–1178.
  10. 10. Tellez JO, Dobrzynski H, Greener ID, Graham GM, Laing E, Honjo H, Hubbard SJ, Boyett MR, Billeter R. (2006) Differential expression of ion channel transcripts in atrial muscle and sinoatrial node in rabbit. Circ Res, 99, 1384–1393.
  11. 11. Larson ED, St Clair JR, Sumner WA, Bannister RA, Proenza C. (2013) Depressed pacemaker activity of sinoatrial node myocytes contributes to the age-dependent decline in maximum heart rate. Proc Natl Acad Sci U S A, 110, 18011–18016.
  12. 12. Rose RA. (2011) Keeping the clocks ticking as we age: changes in sinoatrial node gene expression and function in the ageing heart. Exp Physiol, 96, 1114–1115.
  13. 13. Kalinowski A, Qin Z, Coffey K, Kodali R, Buehler MJ, Losche M, Dahl KN. (2013) Calcium causes a conformational change in lamin A tail domain that promotes farnesyl-mediated membrane association. Biophys J, 104, 2246–2253.
  14. 14. Lo CY, Tjong YW, Ho JC, Siu CW, Cheung SY, Tang NL, Yu S, Tse HF, Yao X. (2014) An upregulation in the expression of vanilloid transient potential channels 2 enhances hypotonicity-induced cytosolic Ca(2)(+) rise in human induced pluripotent stem cell model of Hutchinson-Gillford Progeria. PLoS One, 9, e87273.
  15. 15. Feng Z, Zhang JT. (2000) Central nervous system calcium homeostasis imbalance and brain aging. Sheng Li Ke Xue Jin Zhan, 31, 102–108.
  16. 16. Gibson GE, Peterson C. (1987) Calcium and the aging nervous system. Neurobiol Aging, 8, 329–343.
  17. 17. Hartmann H, Eckert A, Muller WE. (1994) Disturbances of the neuronal calcium homeostasis in the aging nervous system. Life Sci, 55, 2011–2018.
  18. 18. Khachaturian ZS. (1991) Calcium and the aging brain: upsetting a delicate balance? Geriatrics, 46, 78–79, 83.
  19. 19. Khachaturian ZS. (1994) Calcium hypothesis of Alzheimer’s disease and brain aging. Ann N Y Acad Sci, 747, 1–11.
  20. 20. Thibault O, Gant JC, Landfield PW. (2007) Expansion of the calcium hypothesis of brain aging and Alzheimer’s disease: minding the store. Aging Cell, 6, 307–317.
  21. 21. Yamada S, Uchida S, Ohkura T, Kimura R, Yamaguchi M, Suzuki M, Yamamoto M. (1996) Alterations in calcium antagonist receptors and calcium content in senescent brain and attenuation by nimodipine and nicardipine. J Pharmacol Exp Ther, 277, 721–727.
  22. 22. Giovannelli L, Pepeu G. (1989) Effect of age on K+−induced cytosolic Ca2+ changes in rat cortical synaptosomes. J Neurochem, 53, 392–398.
  23. 23. Bruno AM, Huang JY, Bennett DA, Marr RA, Hastings ML, Stutzmann GE. (2012) Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer’s disease. Neurobiol Aging, 33, 1001 e1-6.
  24. 24. Blagosklonny MV. (2008) Aging: ROS or TOR. Cell Cycle, 7, 3344–3354.
  25. 25. Evans JR, Bielefeldt K. (2000) Regulation of sodium currents through oxidation and reduction of thiol residues. Neuroscience, 101, 229–236.
  26. 26. Santarelli LC, Wassef R, Heinemann SH, Hoshi T. (2006) Three methionine residues located within the regulator of conductance for K+ (RCK) domains confer oxidative sensitivity to large-conductance Ca2+−activated K+ channels. J Physiol, 571, 329–348.
  27. 27. Chiamvimonvat N, O’Rourke B, Kamp TJ, Kallen RG, Hofmann F, Flockerzi V, Marban E. (1995) Functional consequences of sulfhydryl modification in the pore-forming subunits of cardiovascular Ca2+ and Na+ channels. Circ Res, 76, 325–334.
  28. 28. Foster TC, Sharrow KM, Masse JR, Norris CM, Kumar A. (2001) Calcineurin links Ca2+ dysregulation with brain aging. J Neurosci, 21, 4066–4073.
  29. 29. Ueda K, Shinohara S, Yagami T, Asakura K, Kawasaki K. (1997) Amyloid beta protein potentiates Ca2+ influx through L-type voltage-sensitive Ca2+ channels: a possible involvement of free radicals. J Neurochem, 68, 265–271.
  30. 30. Todorovic SM, Jevtovic-Todorovic V, Meyenburg A, Mennerick S, Perez-Reyes E, Romano C, Olney JW, Zorumski CF. (2001) Redox modulation of T-type calcium channels in rat peripheral nociceptors. Neuron, 31, 75–85.
  31. 31. Bading H. (2000) Transcription-dependent neuronal plasticity the nuclear calcium hypothesis. Eur J Biochem, 267, 5280–5283.
  32. 32. Hardingham GE, Chawla S, Johnson CM, Bading H. (1997) Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression. Nature, 385, 260–265.
  33. 33. Kelly PT, Mackinnon RL, 2nd, Dietz RV, Maher BJ, Wang J. (2005) Postsynaptic IP3 receptor-mediated Ca2+ release modulates synaptic transmission in hippocampal neurons. Brain Res Mol Brain Res, 135, 232–248.
  34. 34. Liu Q, Chen B, Yankova M, Morest DK, Maryon E, Hand AR, Nonet ML, Wang ZW. (2005) Presynaptic ryanodine receptors are required for normal quantal size at the Caenorhabditis elegans neuromuscular junction. J Neurosci, 25, 6745–6754.
  35. 35. Simkus CR, Stricker C. (2002) The contribution of intracellular calcium stores to mEPSCs recorded in layer II neurones of rat barrel cortex. J Physiol, 545, 521–535.
  36. 36. Suryanarayanan A, Slaughter MM. (2006) Synaptic transmission mediated by internal calcium stores in rod photoreceptors. J Neurosci, 26, 1759–1766.
  37. 37. Unni VK, Zakharenko SS, Zablow L, DeCostanzo AJ, Siegelbaum SA. (2004) Calcium release from presynaptic ryanodine-sensitive stores is required for long-term depression at hippocampal CA3-CA3 pyramidal neuron synapses. J Neurosci, 24, 9612–9622.
  38. 38. West AE, Chen WG, Dalva MB, Dolmetsch RE, Kornhauser JM, Shaywitz AJ, Takasu MA, Tao X, Greenberg ME. (2001) Calcium regulation of neuronal gene expression. Proc Natl Acad Sci U S A, 98, 11024–11031.
  39. 39. Mathew SS, Hablitz JJ. (2008) Calcium release via activation of presynaptic IP3 receptors contributes to kainate-induced IPSC facilitation in rat neocortex. Neuropharmacology, 55, 106–116.
  40. 40. Dropic AJ, Brailoiu E, Cooper RL. (2005) Presynaptic mechanism of action induced by 5-HT in nerve terminals: possible involvement of ryanodine and IP3 sensitive 2+ stores. Comp Biochem Physiol A Mol Integr Physiol, 142, 355–361.
  41. 41. Bezprozvanny I, Hayden MR. (2004) Deranged neuronal calcium signaling and Huntington disease. Biochem Biophys Res Commun, 322, 1310–1317.
  42. 42. Kelliher M, Fastbom J, Cowburn RF, Bonkale W, Ohm TG, Ravid R, Sorrentino V, O’Neill C. (1999) Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer’s disease neurofibrillary and beta-amyloid pathologies. Neuroscience, 92, 499–513.
  43. 43. Smith IF, Hitt B, Green KN, Oddo S, LaFerla FM. (2005) Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer’s disease. J Neurochem, 94, 1711–1718.
  44. 44. Stutzmann GE, Caccamo A, LaFerla FM, Parker I. (2004) Dysregulated IP3 signaling in cortical neurons of knock-in mice expressing an Alzheimer’s-linked mutation in presenilin1 results in exaggerated Ca2+ signals and altered membrane excitability. J Neurosci, 24, 508–513.
  45. 45. Ziegler SI, Haberkorn U, Byrne H, Tong C, Kaja S, Richolt JA, Byrne H, Tong C, Schosser R, Krieter H, Kaja S, Richolt JA, Lammertsma AA, Price P. (1996) Measurement of liver blood flow using oxygen-15 labelled water and dynamic positron emission tomography: limitations of model description. Eur J Nucl Med, 23, 169–177.
  46. 46. Kaja S, Sumien N, Borden PK, Khullar N, Iqbal M, Collins JL, Forster MJ, Koulen P. (2013) Homer-1a immediate early gene expression correlates with better cognitive performance in aging. Age (Dordr), 35, 1799–1808.
  47. 47. Kaja S, Naumchuk Y, Grillo SL, Borden PK, Koulen P. (2014) Differential up-regulation of Vesl-1/Homer 1 protein isoforms associated with decline in visual performance in a preclinical glaucoma model. Vision Res, 94, 16–23.
  48. 48. Kaja S, Sumien N, Shah VV, Puthawala I, Maynard AN, Khullar N, Payne AJ, Forster MJ, Koulen P. (2015) Loss of spatial memory, learning, and motor function during normal aging is accompanied by changes in brain presenilin 1 and 2 expression levels. Mol Neurobiol, 52, 545–554.
  49. 49. Ferreiro E, Resende R, Costa R, Oliveira CR, Pereira CM. (2006) An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity. Neurobiol Dis, 23, 669–678.
  50. 50. Kasri NN, Kocks SL, Verbert L, Hebert SS, Callewaert G, Parys JB, Missiaen L, De Smedt H. (2006) Up-regulation of inositol 1,4,5-trisphosphate receptor type 1 is responsible for a decreased endoplasmic-reticulum Ca2+ content in presenilin double knock-out cells. Cell Calcium, 40, 41–51.
  51. 51. Tang TH, Chang CT, Wang HJ, Erickson JD, Reichard RA, Martin AG, Shannon EK, Martin AL, Huang YW, Aronstam RS. (2013) Oxidative stress disruption of receptor-mediated calcium signaling mechanisms. J Biomed Sci, 20, 48.
  52. 52. Kaja S, Duncan RS, Longoria S, Hilgenberg JD, Payne AJ, Desai NM, Parikh RA, Burroughs SL, Gregg EV, Goad DL, Koulen P. (2011) Novel mechanism of increased Ca2+ release following oxidative stress in neuronal cells involves type 2 inositol-1,4,5-trisphosphate receptors. Neuroscience, 175, 281–291.
  53. 53. Leite MF, Thrower EC, Echevarria W, Koulen P, Hirata K, Bennett AM, Ehrlich BE, Nathanson MH. (2003) Nuclear and cytosolic calcium are regulated independently. Proc Natl Acad Sci U S A, 100, 2975–2980.
  54. 54. Duncan RS, Hwang SY, Koulen P. (2007) Differential inositol 1,4,5-trisphosphate receptor signaling in a neuronal cell line. Int J Biochem Cell Biol, 39, 1852–1862.
  55. 55. Kaja S, Payne AJ, Patel KR, Naumchuk Y, Koulen P. (2015) Differential subcellular Ca2+ signaling in a highly specialized subpopulation of astrocytes. Exp Neurol, 265, 59–68.
  56. 56. Duncan RS, Goad DL, Grillo MA, Kaja S, Payne AJ, Koulen P. (2010) Control of intracellular calcium signaling as a neuroprotective strategy. Molecules, 15, 1168–1195.
  57. 57. Paredes F, Parra V, Torrealba N, Navarro-Marquez M, Gatica D, Bravo-Sagua R, Troncoso R, Pennanen C, Quiroga C, Chiong M, Caesar C, Taylor WR, Molgo J, San Martin A, Jaimovich E, Lavandero S. (2016) HERPUD1 protects against oxidative stress-induced apoptosis through downregulation of the inositol 1,4,5-trisphosphate receptor. Free Radic Biol Med, 90, 206–218.
  58. 58. Joseph JA, Shukitt-Hale B, Casadesus G, Fisher D. (2005) Oxidative stress and inflammation in brain aging: nutritional considerations. Neurochem Res, 30, 927–935.
  59. 59. Jou I, Pyo H, Chung S, Jung SY, Gwag BJ, Joe EH. (1998) Expression of Kv1.5 K+ channels in activated microglia in vivo. Glia, 24, 408–414.
  60. 60. Pannasch U, Farber K, Nolte C, Blonski M, Yan Chiu S, Messing A, Kettenmann H. (2006) The potassium channels Kv1.5 and Kv1.3 modulate distinct functions of microglia. Mol Cell Neurosci, 33, 401–411.
  61. 61. Chung S, Lee J, Joe EH, Uhm DY. (2001) Beta-amyloid peptide induces the expression of voltage dependent outward rectifying K+ channels in rat microglia. Neurosci Lett, 300, 67–70.
  62. 62. Kaja S, Payne AJ, Naumchuk Y, Levy D, Zaidi DH, Altman AM, Nawazish S, Ghuman JK, Gerdes BC, Moore MA, Koulen P. (2015) Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytes. Exp Eye Res, 138, 159–166.
  63. 63. Kaja S, Payne AJ, Singh T, Ghuman JK, Sieck EG, Koulen P. (2015) An optimized lactate dehydrogenase release assay for screening of drug candidates in neuroscience. J Pharmacol Toxicol Methods, 73, 1–6.
  64. 64. Mandal A, Shahidullah M, Delamere NA. (2010) Hydrostatic pressure-induced release of stored calcium in cultured rat optic nerve head astrocytes. Invest Ophthalmol Vis Sci, 51, 3129–3138.
  65. 65. Bazargani N, Attwell D. (2016) Astrocyte calcium signaling: the third wave. Nat Neurosci, 19, 182–189.
  66. 66. Finkel T, Serrano M, Blasco MA. (2007) The common biology of cancer and ageing. Nature, 448, 767–774.
  67. 67. Wright EM. (2001) Renal Na(+)-glucose cotransporters. Am J Physiol Renal Physiol, 280, F10-8.
  68. 68. Wright EM, Hirayama BA, Loo DF. (2007) Active sugar transport in health and disease. J Intern Med, 261, 32–43.
  69. 69. Hogan PG, Chen L, Nardone J, Rao A. (2003) Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev, 17, 2205–2232.
  70. 70. Johnson CM, Hill CS, Chawla S, Treisman R, Bading H. (1997) Calcium controls gene expression via three distinct pathways that can function independently of the Ras/mitogen-activated protein kinases (ERKs) signaling cascade. J Neurosci, 17, 6189–6202.
  71. 71. Rao VR, Perez-Neut M, Kaja S, Gentile S. Voltage-gated ion channels in cancer cell proliferation. Cancers (Basel), 7, 849–875.
  72. 72. Vandenberg JI, Perry MD, Perrin MJ, Mann SA, Ke Y, Hill AP. (2012) hERG K(+) channels: structure, function, and clinical significance. Physiol Rev, 92, 1393–1478.
  73. 73. Arcangeli A. (2005) Expression and role of hERG channels in cancer cells. Novartis Found Symp, 266, 225–232; discussion 232–234.
  74. 74. Ganapathi SB, Kester M, Elmslie KS. (2009) State-dependent block of HERG potassium channels by R-roscovitine: implications for cancer therapy. Am J Physiol Cell Physiol, 296, C701-10.
  75. 75. Glassmeier G, Hempel K, Wulfsen I, Bauer CK, Schumacher U, Schwarz JR. (2012) Inhibition of HERG1 K+ channel protein expression decreases cell proliferation of human small cell lung cancer cells. Pflugers Arch, 463, 365–376.
  76. 76. Lansu K, Gentile S. Potassium channel activation inhibits proliferation of breast cancer cells by activating a senescence program. Cell Death Dis, 4, e652.
  77. 77. Perez-Neut M, Rao VR, Gentile S. hERG1/Kv11.1 activation stimulates transcription of p21waf/cip in breast cancer cells via a calcineurin-dependent mechanism. Oncotarget.
  78. 78. Perez-Neut M, Shum A, Cuevas BD, Miller R, Gentile S. Stimulation of hERG1 channel activity promotes a calcium-dependent degradation of cyclin E2, but not cyclin E1, in breast cancer cells. Oncotarget, 6, 1631–1639.
  79. 79. Hayflick L, Moorhead PS. (1961) The serial cultivation of human diploid cell strains. Exp Cell Res, 25, 585–621.
  80. 80. Campisi J. (2000) Cancer, aging and cellular senescence. In Vivo, 14, 183–188.
  81. 81. Munoz-Espin D, Serrano M. (2014) Cellular senescence: from physiology to pathology. Nat Rev Mol Cell Biol, 15, 482–496.
  82. 82. Rodier F, Campisi J. (2011) Four faces of cellular senescence. J Cell Biol, 192, 547–556.
  83. 83. Lansu K, Gentile S. (2013) Potassium channel activation inhibits proliferation of breast cancer cells by activating a senescence program. Cell Death Dis, 4, e652.
  84. 84. Perez-Neut M, Rao VR, Gentile S. (2014) hERG1/Kv11.1 activation stimulates transcription of p21waf/cip in breast cancer cells via a calcineurin-dependent mechanism. Oncotarget.
  85. 85. Perez-Neut M, Shum A, Cuevas BD, Miller R, Gentile S. (2014) Stimulation of hERG1 channel activity promotes a calcium-dependent degradation of cyclin E2, but not cyclin E1, in breast cancer cells. Oncotarget, 6, 1631–1639.
  86. 86. Leong HS, Robertson AE, Stoletov K, Leith SJ, Chin CA, Chien AE, Hague MN, Ablack A, Carmine-Simmen K, McPherson VA, Postenka CO, Turley EA, Courtneidge SA, Chambers AF, Lewis JD. (2014) Invadopodia are required for cancer cell extravasation and are a therapeutic target for metastasis. Cell Rep, 8, 1558–1570.
  87. 87. Sontheimer H. (2008) An unexpected role for ion channels in brain tumor metastasis. Exp Biol Med (Maywood), 233, 779–791.
  88. 88. Pardo LA, del Camino D, Sanchez A, Alves F, Bruggemann A, Beckh S, Stuhmer W. (1999) Oncogenic potential of EAG K(+) channels. EMBO J, 18, 5540–5547.
  89. 89. Wu X, Zhong D, Lin B, Zhai W, Ding Z, Wu J. (2013) p38 MAPK regulates the expression of ether a go-go potassium channel in human osteosarcoma cells. Radiol Oncol, 47, 42–49.
  90. 90. Hassan MS, Ansari J, Spooner D, Hussain SA. (2010) Chemotherapy for breast cancer (Review). Oncol Rep, 24, 1121–1131.
  91. 91. Michaud JE, Billups KL, Partin AW. (2015) Testosterone and prostate cancer: an evidence-based review of pathogenesis and oncologic risk. Ther Adv Urol, 7, 378–387.
  92. 92. Gentile S, Darden T, Erxleben C, Romeo C, Russo A, Martin N, Rossie S, Armstrong DL. (2006) Rac GTPase signaling through the PP5 protein phosphatase. Proc Natl Acad Sci U S A, 103, 5202–5206.
  93. 93. Simoncini T, Genazzani AR. (2003) Non-genomic actions of sex steroid hormones. Eur J Endocrinol, 148, 281–292.
  94. 94. Storey NM, Gentile S, Ullah H, Russo A, Muessel M, Erxleben C, Armstrong DL. (2006) Rapid signaling at the plasma membrane by a nuclear receptor for thyroid hormone. Proc Natl Acad Sci U S A, 103, 5197–5201.
  95. 95. Draznin B. (1988) Intracellular calcium, insulin secretion, and action. Am J Med, 85, 44–58.
  96. 96. Kaja S, Payne AJ, Burroughs SL, Koulen P. (2013) Homer. In: Encyclopedia of Signaling Molecules (ed. S Choi). Springer.
  97. 97. Westhoff JH, Hwang SY, Duncan RS, Ozawa F, Volpe P, Inokuchi K, Koulen P. (2003) Vesl/Homer proteins regulate ryanodine receptor type 2 function and intracellular calcium signaling. Cell Calcium, 34, 261–269.
  98. 98. Duncan RS, Hwang SY, Koulen P. (2005) Effects of Vesl/Homer proteins on intracellular signaling. Exp Biol Med (Maywood), 230, 527–535.
  99. 99. Hwang SY, Wei J, Westhoff JH, Duncan RS, Ozawa F, Volpe P, Inokuchi K, Koulen P. (2003) Differential functional interaction of two Vesl/Homer protein isoforms with ryanodine receptor type 1: a novel mechanism for control of intracellular calcium signaling. Cell Calcium, 34, 177–184.
  100. 100. Kaja S, Yang SH, Wei J, Fujitani K, Liu R, Brun-Zinkernagel AM, Simpkins JW, Inokuchi K, Koulen P. (2003) Estrogen protects the inner retina from apoptosis and ischemia-induced loss of Vesl-1L/Homer 1c immunoreactive synaptic connections. Invest Ophthalmol Vis Sci, 44, 3155–3162.
  101. 101. Payne AJ, Gerdes BC, Naumchuk Y, McCalley AE, Kaja S, Koulen P. (2013) Presenilins regulate the cellular activity of ryanodine receptors differentially through isotype-specific N-terminal cysteines. Exp Neurol, 250, 143–150.
  102. 102. Payne AJ, Kaja S, Koulen P. (2015) Regulation of ryanodine receptor-mediated calcium signaling by presenilins. Receptors Clin Investig, 2, e449.
  103. 103. Rybalchenko V, Hwang SY, Rybalchenko N, Koulen P. (2008) The cytosolic N-terminus of presenilin-1 potentiates mouse ryanodine receptor single channel activity. Int J Biochem Cell Biol, 40, 84–97.
  104. 104. Hayrapetyan V, Rybalchenko V, Rybalchenko N, Koulen P. (2008) The N-terminus of presenilin-2 increases single channel activity of brain ryanodine receptors through direct protein-protein interaction. Cell Calcium, 44, 507–518.27.
  105. 105. Chiamvimonvat N, O’Rourke B, Kamp TJ, Kallen RG, Hofmann F, Flockerzi V, Marban E. (1995) Functional consequences of sulfhydryl modification in the pore-forming subunits of cardiovascular Ca2+ and Na+ channels. Circ Res, 76, 325–334.

Written By

Vidhya Rao, Simon Kaja and Saverio Gentile

Submitted: 06 November 2015 Reviewed: 26 April 2016 Published: 31 August 2016